|
Vincent A. Miller, MD, is an Associate Attending Physician on the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center and Associate Professor of Medicine at Weill Medical College of Cornell University. Dr. Miller’s main research focus is on drug development and the treatment of non–small cell lung carcinoma. His initial work was central to the approval of bexarotene in CTCL and docetaxel in NSCLC. More recently, Dr. Miller has been a leader in the development of therapies targeted at the HER family of receptors. His collaborative work has been central to gaining an understanding of the clinical and molecular predictors of sensitivity and resistance to erlotinib and gefitinib in NSCLC. Dr. Miller has received both the prestigious American Cancer Society Clinical Oncology Career Development Award and the Louise and Allston Boyer Award. Dr. Miller currently serves as a Track Leader in Lung Cancer for the ASCO Cancer Education Committee. Dr. Miller earned a BS in Mathematics at the University of Pennsylvania where he was honored as a Benjamin Franklin Scholar and then received his M.D. at the University of Medicine and Dentistry of New Jersey in Newark. He completed an internship and residency and then served as Chief Medical Resident in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia, and subsequently a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center. | 